Literature DB >> 28543357

Associations of TNF-α -238 A/G and IL-10 -1082 G/A Genetic Polymorphisms With the Risk of NONFH in the Chinese Population.

Biao-Fang Wei1, Zhi Feng1, Wei Wei2, Xiao Chen3.   

Abstract

The study aims to explore the roles of common polymorphisms of Tumor Necrosis Factor-α (TNF-α) (-238 A/G and -308 A/G) and IL-10 (-819 T/C and -1082 G/A) genes in the risk of non-traumatic osteonecrosis of the femoral head (NONFH). One hundred and forty-seven NONFH patients and 135 healthy individuals were selected as the case and control groups. qRT-PCR and Western blotting techniques detected mRNA as well as protein expressions of TNF-α and IL-10 of each genotype in both the case and control groups. The GA genotype and the A allele of TNF-α -238 A/G were higher in the case group than in the control group. Compared with the control group, AA, GA, and AG + AA genotypes as well as the A allele of IL-10-1082 G/A were all lower in the case group. In the case groups increased levels of TNF-α as well as decreased levels of IL-10 expression when compared with the control group. TNF-α expression of TNF-α-238 GA genotype was significantly higher than that in patients with GG genotype, while the IL-10 expression of GA and AA genotypes of IL-10-1082 was significantly lower than in that of patients with the GG genotype. TNF-α protein expression in the GA genotype was significantly higher than in the GG genotype. In relation to TNF-α -238, TNF-α protein expression of GA and AA genotypes had significantly reduced more so than the GG genotype in IL-10-1082. TNF-α-238 A/G and IL-10-1082 G/A may be involved as risk factors of NONFH. J. Cell. Biochem. 118: 4872-4880, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  BLOOD LIPID LEVEL; GENE POLYMORPHISMS; GENOTYPE; INTERLEUKIN-10; NON-TRAUMATIC OSTEONECROSIS OF FEMORAL HEAD; TUMOR NECROSIS FACTOR α

Mesh:

Substances:

Year:  2017        PMID: 28543357     DOI: 10.1002/jcb.26167

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

Review 1.  Association of TNF-α-308(G/A) and -238(G/A) polymorphisms with non-traumatic osteonecrosis of the femoral head risks: a meta-analysis.

Authors:  Yizhong Peng; Yuenan Liu; Donghua Huang; Wei Huang; Zengwu Shao
Journal:  Int Orthop       Date:  2018-03-07       Impact factor: 3.075

2.  Osteonecrosis of the femoral head: genetic basis.

Authors:  Tracy Wang; Bouziane Azeddine; Wayne Mah; Edward J Harvey; David Rosenblatt; Chantal Séguin
Journal:  Int Orthop       Date:  2018-10-17       Impact factor: 3.075

3.  Genetic polymorphisms in tumor necrosis factor alpha and interleukin-10 are associated with an increased risk of cervical cancer.

Authors:  Guang-Hui Du; Jun-Kang Wang; Jackson R Richards; Jia-Jia Wang
Journal:  Int Immunopharmacol       Date:  2018-11-16       Impact factor: 4.932

4.  DNA methylation in the OPG/RANK/RANKL pathway is associated with steroid-induced osteonecrosis of the femoral head.

Authors:  Menghu Sun; Yuju Cao; Xiaolong Yang; Feimeng An; Huiqiang Wu; Jianzhong Wang
Journal:  BMC Musculoskelet Disord       Date:  2021-06-29       Impact factor: 2.362

5.  Involvement of tumor necrosis factor alpha in steroid-associated osteonecrosis of the femoral head: friend or foe?

Authors:  Bin Fang; Ding Wang; Jiaqian Zheng; Qiushi Wei; Dongxiang Zhan; Yamei Liu; Xuesong Yang; Haibin Wang; Gang Li; Wei He; Liangliang Xu
Journal:  Stem Cell Res Ther       Date:  2019-01-03       Impact factor: 6.832

6.  No association between three polymorphisms (rs1800629, rs361525 and rs1799724) in the tumor necrosis factor-α gene and susceptibility to prostate cancer: a comprehensive meta-analysis.

Authors:  Lei Yin; Chuang Yue; Hongwei Jing; Hongyuan Yu; Li Zuo; Tao Liu
Journal:  Hereditas       Date:  2020-04-07       Impact factor: 3.271

7.  Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation.

Authors:  Jukka Partanen; Kati Hyvärinen; Heike Bickeböller; Katarzyna Bogunia-Kubik; Rachel E Crossland; Milena Ivanova; Francesca Perutelli; Ralf Dressel
Journal:  Front Immunol       Date:  2020-10-19       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.